Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pediatric Hematology/Oncology
•
General Internal Medicine
•
Rheumatology
•
Hematology
•
Pediatric Hematology
•
Lupus nephritis
•
Antiphospholipid Syndrome
•
Nephrology
•
Glomerulonephritis
•
Anticoagulation
In patients with lupus nephritis, and MAHA with positive anti-phospholipid autoantibodies, what are the considerations to use or not use anti-coagulation therapy?
Related Questions
Can anti-cardiolipin or anti-beta-2 glycoprotein antibodies cause prolonged PTT in the absence of a lupus anticoagulant?
Can lupus anticoagulant be positive despite a normal aPTT?
What is your threshold to repeat a kidney biopsy in a patient with a history of lupus nephritis who is on maintenance therapy and develops subtle changes in urinary protein excretion or microscopic hematuria?
What steroid regimen do you typically use for induction therapy in patients with lupus nephritis?
How would you approach management of a patient with ESRD on the transplant list who is found to have high titer APS labs (ACL, B2GP1, LAC)?
How would you approach post-operative VTE prophylaxis for renal transplant in patients with a prior history of provoked VTE?
What do you feel are the potential barriers to widespread use of obinutuzumab in proliferative lupus nephritis?
Do you ever combine voclosporin and belimumab in the treatment of lupus nephritis?
What drives you to choose voclospsorin over tacrolimus given the substantially higher cost?
How do you approach the management of patients with suspected membranous lupus nephritis who are found to have positive PLA2R antibodies?